½ÃÀ庸°í¼­
»óǰÄÚµå
1468316

¾È°ú ÀÇ·á±â±â ½ÃÀå º¸°í¼­ : Á¦Ç° À¯Çü, ¿ëµµ, ÃÖÁ¾ ¿ëµµ, Áö¿ªº°(2024-2032³â)

Ophthalmic Devices Market Report by Product Type, Application, End Use, and Region 2024-2032

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: IMARC | ÆäÀÌÁö Á¤º¸: ¿µ¹® 135 Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°è ¾È°ú ÀÇ·á±â±â ½ÃÀå ±Ô¸ð´Â 2023³â 276¾ï ´Þ·¯¿¡ ´ÞÇß½À´Ï´Ù. ÇâÈÄ IMARC GroupÀº 2032³â±îÁö ½ÃÀå ±Ô¸ð°¡ 385¾ï ´Þ·¯¿¡ ´ÞÇØ 2024-2032³â »çÀÌ 3.7%ÀÇ ¿¬Æò±Õ ¼ºÀå·ü(CAGR)À» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹ÃøÇß½À´Ï´Ù.

¾È°ú ÀÇ·á±â±â´Â ¿Ü°úÀû Áø´Ü ¹× ½Ã·Â ±³Á¤¿¡ »ç¿ëµÇ´Â ÀÇ·á±â±âÀÔ´Ï´Ù. ÄÜÅÃÆ®·»Áî, ÄÜÅÃÆ®·»Áî °ü¸® Á¦Ç°, Áø´Ü¾à, ÀÓÇöõÆ®, Àΰø¼öÁ¤Ã¼(IOL), ·¹ÀÌÀú, ÃÊÀ½ÆÄ À¯È­ ½Ã½ºÅÛ, Àΰø´«¹°, ¼ö¼ú±â±¸ µîÀ¸·Î ±¸¼ºµË´Ï´Ù. À̵éÀº ¾È±¸ ÀÌ»ó, °á¼Õ ¹× ±âŸ ¾È°ú ÁúȯÀÇ Áø´Ü ¹× Ä¡·á¿¡ »ç¿ëµË´Ï´Ù. Ä¡·á ½Ã°£À» ´ÜÃàÇÏ°í ¾çÁúÀÇ ¾È°ú ÀǷḦ Á¦°øÇÔÀ¸·Î½á ȯÀÚ¿Í ¾È°ú Àǻ翡°Ô ¾È°ú Ä¡·á¸¦ º¸´Ù Æí¸®ÇÏ°Ô ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÇöÀç ¹é³»Àå, ³ì³»Àå µî ¾È°ú ÁúȯÀÇ À¯º´·üÀÌ Áõ°¡ÇÔ¿¡ µû¶ó Àü ¼¼°èÀûÀ¸·Î ¾È°ú ÀÇ·á±â±â¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

¾È°ú ÀÇ·á±â±â ½ÃÀå µ¿Çâ:

³ëÆ®ºÏ, ½º¸¶Æ®Æù, PC, ÀüÀÚÃ¥ ¸®´õ±â µî µðÁöÅÐ ±â±â¿¡ ´ëÇÑ ÀÇÁ¸µµ°¡ ³ô¾ÆÁö´Â °ÍÀº ½ÃÀåÀ» °ßÀÎÇÏ´Â Áß¿äÇÑ ¿äÀÎ Áß ÇϳªÀÔ´Ï´Ù. ¶ÇÇÑ ±Ù°Å¸® ¹× ¿ø°Å¸® ½Ã·Â ȸº¹À» À§ÇØ Àΰø¼öÁ¤Ã¼(IOL)ÀÇ »ç¿ëÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀÌ´Â ÀÇ·á »ê¾÷ÀÇ È®Àå°ú ÇÔ²² ½ÃÀå ¼ºÀåÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¾È°ú Àü¹®°¡µé »çÀÌ¿¡¼­ ¾È°ú Áúȯ ¹× °ü·Ã ÇÕº´ÁõÀ» Ä¡·áÇϱâ À§ÇÑ °í°´ ±³À° ¹× ±³À°ÀÌ ÀÌ·ç¾îÁö°í ÀÖ´Â °Íµµ ½ÃÀå¿¡ ±àÁ¤ÀûÀÎ ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÁÖ¿ä ½ÃÀå Âü¿©ÀÚµéÀº ½Ã·Â ¿À·ù¸¦ Ä¡·áÇÏ´Â »õ·Î¿î ÀåÄ¡ °³¹ßÀ» À§ÇÑ ¿¬±¸ °³¹ß(R&D) Ȱµ¿¿¡ ¸¹Àº ÅõÀÚ¸¦ Çϰí ÀÖ½À´Ï´Ù. ÀÌ´Â ¾È°ú ÀÇ·á±â±â¿¡ ´ëÇÑ °³ÀεéÀÇ ÀνÄÀÌ ³ô¾ÆÁü¿¡ µû¶ó ¾÷°è ÅõÀÚÀڵ鿡°Ô À¯¸®ÇÑ ¼ºÀå ±âȸ¸¦ Á¦°øÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, °æÁõ ¹× Áߵ ³ì³»Àå Ä¡·á¸¦ À§ÇÑ ¹Ì¼¼Ä§½ÀÀû ³ì³»Àå(MIGs) ¼ö¼ú¿ë ÀÓÇöõÆ®ÀÇ Ã¤ÅÃÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀÌ¿¡ µû¶ó ¿©·¯ ±¹°¡ÀÇ Á¤ºÎ°¡ ´« °Ç°­À» ÁõÁøÇϱâ À§ÇÑ ³ë·ÂÀ» ±â¿ïÀ̰í ÀÖÀ¸¸ç, ÀÌ´Â ½ÃÀå ¼ºÀåÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

º» º¸°í¼­¿¡¼­ ´Ù·ç´Â ÁÖ¿ä Áú¹®µé

  • 2023³â ¼¼°è ¾È°ú ÀÇ·á±â±â ½ÃÀå ±Ô¸ð´Â?
  • 2024-2032³â ¼¼°è ¾È°ú ÀÇ·á±â±â ½ÃÀåÀÇ ¿¹»ó ¼ºÀå·üÀº?
  • ¼¼°è ¾È°ú ÀÇ·á±â±â ½ÃÀåÀ» À̲ô´Â ÁÖ¿ä ¿äÀÎÀº ¹«¾ùÀΰ¡?
  • COVID-19°¡ ¾È°ú ÀÇ·á±â±â ¼¼°è ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâÀº?
  • Á¦Ç° À¯Çüº° ¾È°ú ÀÇ·á±â±â ¼¼°è ½ÃÀå ÇöȲÀº?
  • ¼¼°è ¾È°ú ÀÇ·á±â±â ½ÃÀåÀÇ ÃÖÁ¾ ¿ëµµº° ºÐ·ù´Â?
  • ¼¼°è ¾È°ú ÀÇ·á±â±â ½ÃÀåÀÇ ÁÖ¿ä Áö¿ªÀº?
  • ¼¼°è ¾È°ú ÀÇ·á±â±â ½ÃÀåÀÇ ÁÖ¿ä ÁøÃâ ±â¾÷Àº?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹üÀ§¿Í Á¶»ç ¹æ¹ý

  • Á¶»ç ¸ñÀû
  • ÀÌÇØ°ü°èÀÚ
  • µ¥ÀÌÅÍ ¼Ò½º
    • 1Â÷ Á¤º¸
    • 2Â÷ Á¤º¸
  • ½ÃÀå ÃßÁ¤
    • »óÇâ½Ä Á¢±Ù
    • ÇÏÇâ½Ä Á¢±Ù
  • Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ¼Ò°³

  • °³¿ä
  • ÁÖ¿ä »ê¾÷ µ¿Çâ

Á¦5Àå ¼¼°èÀÇ ¾È°ú ÀÇ·á±â±â ½ÃÀå

  • ½ÃÀå °³¿ä
  • ½ÃÀå ½ÇÀû
  • COVID-19ÀÇ ¿µÇâ
  • ½ÃÀå ¿¹Ãø

Á¦6Àå ½ÃÀå ³»¿ª : Á¦Ç° À¯Çüº°

  • ¿Ü°ú¿ë
    • ½ÃÀå µ¿Çâ
    • ÁÖ¿ä ºÎ¹®
      • ÀÓÇöõÆ®
      • ¼Ò¸ðǰ
      • ±â±â
    • ½ÃÀå ¿¹Ãø
  • ºñÀü Äɾî
    • ½ÃÀå µ¿Çâ
    • ÁÖ¿ä ºÎ¹®
      • ÄÜÅÃÆ®·»Áî
      • ´« °Ç°­
    • ½ÃÀå ¿¹Ãø

Á¦7Àå ½ÃÀå ³»¿ª : ¿ëµµº°

  • ¹é³»Àå
  • À¯¸®Ã¼¸Á¸· Áúȯ
  • ³ì³»Àå
  • ±¼Àý Àå¾Ö

Á¦8Àå ½ÃÀå ³»¿ª : ÃÖÁ¾ ¿ëµµº°

  • º´¿ø¡¤¾È°ú Ŭ¸®´Ð
  • ´ëÇС¤¿¬±¸¼Ò
  • ±âŸ

Á¦9Àå ½ÃÀå ³»¿ª : Áö¿ªº°

  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • Áß±¹
    • ÀϺ»
    • Àεµ
    • Çѱ¹
    • È£ÁÖ
    • Àεµ³×½Ã¾Æ
    • ±âŸ
  • À¯·´
    • µ¶ÀÏ
    • ÇÁ¶û½º
    • ¿µ±¹
    • ÀÌÅ»¸®¾Æ
    • ½ºÆäÀÎ
    • ·¯½Ã¾Æ
    • ±âŸ
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • ºê¶óÁú
    • ¸ß½ÃÄÚ
    • ±âŸ
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • ½ÃÀå µ¿Çâ
    • ½ÃÀå ³»¿ª : ±¹°¡º°
    • ½ÃÀå ¿¹Ãø

Á¦10Àå SWOT ºÐ¼®

  • °³¿ä
  • °­Á¡
  • ¾àÁ¡
  • ±âȸ
  • À§Çù

Á¦11Àå ¹ë·ùüÀÎ ºÐ¼®

Á¦12Àå Porter's Five Forces ºÐ¼®

  • °³¿ä
  • ±¸¸ÅÀÚÀÇ ±³¼··Â
  • °ø±Þ ±â¾÷ÀÇ ±³¼··Â
  • °æÀï Á¤µµ
  • ½Å±Ô Âü¿©¾÷üÀÇ À§Çù
  • ´ëüǰÀÇ À§Çù

Á¦13Àå °¡°Ý ºÐ¼®

Á¦14Àå °æÀï »óȲ

  • ½ÃÀå ±¸Á¶
  • ÁÖ¿ä ±â¾÷
  • ÁÖ¿ä ±â¾÷ °³¿ä
    • Bausch & Lomb Incorporated(Bausch Health Companies Inc.)
    • Carl Zeiss Meditec AG
    • EssilorLuxottica SA
    • Haag-Streit Group
    • HOYA Surgical Optics GmbH(Hoya Corporation)
    • Leica Microsystems GmbH(Danaher Corporation)
    • Nidek Co Ltd.
    • Topcon Corporation
    • Volk Optical Inc.
    • Ziemer Ophthalmic Systems AG
ksm 24.05.10

The global ophthalmic devices market size reached US$ 27.6 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 38.5 Billion by 2032, exhibiting a growth rate (CAGR) of 3.7% during 2024-2032.

Ophthalmic devices are medical equipment used for surgical diagnosis and vision correction. They comprise contact lenses, contact lens care products, diagnostics, implants, intraocular lenses (IOLs), lasers, phacoemulsification systems, artificial tears, and surgical instruments. They are used to diagnose and cure ocular abnormalities or deficits, and other eye diseases. They aid in making the eye-treatment procedure more convenient for patients and ophthalmologists by reducing treatment time and providing high-quality eye care. At present, due to the rising prevalence of ophthalmic diseases, such as cataracts and glaucoma, there is an increase in the demand for ophthalmic devices across the globe.

Ophthalmic Devices Market Trends:

The growing reliance on digital devices, such as laptops, smartphones, computers and e-readers, represents one of the key factors driving the market. Moreover, there is a rise in the utilization of intraocular lenses (IOLs) to replace the natural lens of eyes for restoring both near and distant vision. This, along with the expanding healthcare industry, is propelling the growth of the market. In addition, the growing customer training and education among eye care professionals to cure eye diseases and associated complications is positively influencing the market. Besides this, key market players are extensively investing in research and development (R&D) activities for the development of novel devices to treat vision errors. This, coupled with the rising awareness about ophthalmic devices among individuals, is offering lucrative growth opportunities to industry investors. Additionally, there is an increase in the employment of micro-invasive glaucoma (MIGs) surgical implants for the treatment of mild to moderate glaucoma. In line with this, governments of several countries are undertaking initiatives to promote eye health, which is bolstering the market growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global ophthalmic devices market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product type, application and end use.

Breakup by Product Type:

Surgical

Implants

Consumables

Equipment

Vision Care

Contact Lens

Ocular Health

Breakup by Application:

Cataract

Vitreo Retinal Disorders

Glaucoma

Refractor Disorders

Breakup by End Use:

Hospitals and Eye Clinics

Academic and Research Laboratory

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Bausch & Lomb Incorporated (Bausch Health Companies Inc.), Carl Zeiss Meditec AG, EssilorLuxottica SA, Haag-Streit Group, HOYA Surgical Optics GmbH (Hoya Corporation), Leica Microsystems GmbH (Danaher Corporation), Nidek Co Ltd., Topcon Corporation, Volk Optical Inc. and Ziemer Ophthalmic Systems AG.

Key Questions Answered in This Report

  • 1. What was the size of the global ophthalmic devices market in 2023?
  • 2. What is the expected growth rate of the global ophthalmic devices market during 2024-2032?
  • 3. What are the key factors driving the global ophthalmic devices market?
  • 4. What has been the impact of COVID-19 on the global ophthalmic devices market?
  • 5. What is the breakup of the global ophthalmic devices market based on the product type?
  • 6. What is the breakup of the global ophthalmic devices market based on the end use?
  • 7. What are the key regions in the global ophthalmic devices market?
  • 8. Who are the key players/companies in the global ophthalmic devices market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Ophthalmic Devices Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product Type

  • 6.1 Surgical
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Implants
      • 6.1.2.2 Consumables
      • 6.1.2.3 Equipment
    • 6.1.3 Market Forecast
  • 6.2 Vision Care
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Contact Lens
      • 6.2.2.2 Ocular Health
    • 6.2.3 Market Forecast

7 Market Breakup by Application

  • 7.1 Cataract
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Vitreo Retinal Disorders
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Glaucoma
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Refractor Disorders
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by End Use

  • 8.1 Hospitals and Eye Clinics
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Academic and Research Laboratory
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Bausch & Lomb Incorporated (Bausch Health Companies Inc.)
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 SWOT Analysis
    • 14.3.2 Carl Zeiss Meditec AG
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 EssilorLuxottica SA
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
    • 14.3.4 Haag-Streit Group
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5 HOYA Surgical Optics GmbH (Hoya Corporation)
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 Leica Microsystems GmbH (Danaher Corporation)
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
    • 14.3.7 Nidek Co Ltd.
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 SWOT Analysis
    • 14.3.8 Topcon Corporation
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
    • 14.3.9 Volk Optical Inc.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
    • 14.3.10 Ziemer Ophthalmic Systems AG
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦